Research in nephrology has been on the rise over the past 5 years and data show that the future is bright for both innovators and people living with kidney diseases. This glimmer of hope was displayed throughout Kidney Week, during which both people living with kidney diseases and kidney health professionals came together to learn and discuss the current and future state of clinical research.

Small dialysis chains and independent dialysis facilities continue to disappear, increasing the risk of monopolies, particularly in small markets, according to an abstract presented at Kidney Week 2019.

KidneyX was established in April 2018 as a public-private partnership between the American Society of Nephrology (ASN) and the Department of Health and Human Services (HHS) with a mission to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.

The one-two punch of Hurricanes Irma and Maria in the United States and the Caribbean in 2017 was a wake-up call to the nephrology community and first responders. The twin disasters left more than 56,000 dialysis patients in the lurch, and kidney transplant patients in destroyed communities desperately seeking immunosuppressive medications.

Seamlessly carrying on the energy of change and transformation in the kidney sphere captured during plenary sessions at Kidney Week 2019, two sessions brought the potential for such transformation to life: Disruptors on the Move and Organs-on-Chips: Human Kidney Microphysiological Systems.

Very few patients who begin urgent in-center hemodialysis transition to home dialysis early, and the survival of those who do varies by modality, according to research presented at Kidney Week 2019.

ASN Kidney Week is unique among medical society gatherings for elevating the patient voice during the annual meeting. Accelerating innovation and discovery in the kidney disease space makes including the perspectives of people with kidney disease in scientific meetings and other forums essential.